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Abstract
Background
Despite significant public health implications, the extent to which community-based condom
distribution interventions (CDI) prevent HIV infection in the United States is not well
understood.
Methods
We systematically reviewed research evidence applying Cochrane Collaboration methods.
We used a comprehensive search strategy to search multiple bibliographic databases for
relevant randomized controlled trials (RCTs) and non-RCTs published from 1986–2017. We
focused on CDI that made condoms widely available or accessible in community settings.
Eligible outcomes were HIV infection (primary), sexually transmitted infections, condom
use, and multiple sexual partnership. Two reviewers independently screened citations to
assess their eligibility, extracted study data, and assessed risk of bias. We calculated risk
ratios (RR) with 95% confidence intervals (CI) and pooled them using random-effects mod-
els. We assessed evidence quality using GRADE.
Results
We reviewed 5,110 unique records. Nine studies (including one RCT) met eligibility criteria.
Studies were conducted in 10 US states between 1989 and 2011. All studies were at high
risk of bias. Interventions were categorized into three groups: “Ongoing” (unlimited access
to condoms), “Ongoing-plus” (unlimited access to condoms, with co-interventions), and
“Coupon-based” (coupons redeemed for condoms). No studies reported incident HIV.
Ongoing CDI (four non-RCTs) modestly reduced condomless sex (RR 0.88, 95% CI 0.78 to
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0.99). Ongoing-plus CDI (two non-RCTs) significantly reduced multiple sexual partnership
(RR 0.37, 95% CI 0.16 to 0.87). Of two coupon-based studies, one (non-RCT) showed
reduction in condomless sex in female participants (Odds Ratio 0.67, 95% CI 0.47 to 0.96),
while the other one (RCT) showed no effect on STI incidence (RR 0.91, 95% CI 0.63 to
1.31). Evidence quality was “very low” for all outcomes.
Conclusions
CDI may reduce some risky sexual behaviors, but the evidence for any reduction is limited
and of low-quality. Lack of biological outcomes precludes assessing the link between CDI
and HIV incidence.
Introduction
Transmission of human immunodeficiency virus (HIV) remains a serious problem in the
United States (US). There were over 44,000 new HIV diagnoses in the US in 2014, primarily
(93%) acquired through sexual transmission [1]. Most new infections occur in people who do
not use condoms or use them inconsistently or incorrectly [2].
Although an estimated 86% of the 1.2 million people living with HIV in the US have been
diagnosed and 40% are in care [3], the remainder do not yet know they have the infection and
may transmit it to others. Similarly, many HIV-uninfected people do not know the HIV status
of their sexual partners [4]. Most HIV-diagnosed patients who are in care in the US receive
antiretroviral therapy (ART), which is highly effective in suppressing HIV viral load and thus
helps to prevent HIV transmission [5, 6]. However, many patients do not maintain the high
level of medication adherence necessary to keep viral load suppressed [7, 8], and may still
transmit HIV to their sexual partners.
Regardless of a person’s HIV status awareness or ART adherence level, it is estimated that
the correct and consistent use of condoms reduces the risk of sexual transmission of HIV
infection by 70% in men who have sex with men (MSM) [9] and 70% in heterosexual couples
[10]. Therefore, condom distribution interventions (CDI) have for many years been a main-
stay of public health HIV prevention efforts at the federal, state, and local levels. CDI often aim
to make condoms widely available, acceptable, and/or accessible to target populations, and
they are often implemented in conjunction with other interventions (“co-interventions”) to
directly or indirectly enhance the effect of condom distribution by addressing knowledge, atti-
tudes, behaviors, and the social and economic contexts influencing condom use. However, the
degree to which such programs actually have an impact on HIV incidence, particularly in vari-
ous risk groups, and the effect of co-interventions on HIV outcomes are poorly understood.
There are two systematic reviews [11, 12] that focused on the effect of condom distribution in
community settings for preventing HIV infection internationally. However, each review defined
“community” differently. While Charania [11] considered the term to reflect organizations and
institutions serving non-geographically defined sub-populations (e.g., “the gay community”),
Moreno [12] understood “community” in terms of a city, district, or other geographic demarca-
tion. While neither sense of the term is incorrect, as a practical matter it is likely better for sys-
tematic reviews to include studies using both concepts. Further, Charania [11] included both
randomized controlled trials (RCTs) and non-RCTs comprising several US-based studies, while
Moreno (2014) included only RCTs, but none from the US. The reviews had no overlap among
Systematic review and meta-analysis of community-based condom distribution interventions in the US
PLOS ONE | https://doi.org/10.1371/journal.pone.0180718 August 3, 2017 2 / 19
concurrence on publication, but the decision to
publish was made by UCSF. The findings and
conclusions in this report are those of the authors
and do not necessarily represent the views of the
Centers for Disease Control and Prevention.
Competing interests: The authors have declared
that no competing interests exist.
included studies, neither found evidence that CDI reduced the risk of HIV incidence, and both
found evidence for improvement in sexual risk behavioral outcomes.
Rationale for this review
Charania’s review [11] is now out of date, as its searches were conducted in 2007. Moreno’s
review [12] was too narrowly framed in terms of eligible study designs and conceptualization
of “community” to capture studies from the US. Given the overall limitations of this evidence-
base, we conducted a systematic review to provide an up-to-date assessment of the impact of
community-based CDI on HIV incidence among general and high-risk populations in the US,
and we estimate added value of co-interventions.
Methods
Throughout the review, we developed and applied methods based on those of the Cochrane
Collaboration [13] and reported findings according to Preferred Reporting Items for System-
atic Reviews and Meta-Analyses recommendations (PRISMA; S1 File) [14]. Our protocol (S2
File) was reviewed and approved by the CDC’s Division of HIV and AIDS Prevention on July
18, 2015.
Eligibility criteria
We used the population, intervention, comparator, and outcome (PICO) schema to detail our
study eligibility criteria.
Population. Eligible studies included the sexually active general population (per defini-
tions by study investigators) and populations at high risk of acquiring or transmitting HIV
infection (adolescents age 10–19; heterosexual adults who have multiple sex partners, who fre-
quently change sex partners, or whose sexual behaviors otherwise could be considered to
increase HIV risk; homeless people; MSM; people who inject drugs, and sex workers). We
excluded studies targeting populations in closed institutional settings (e.g., jails, hospitals). We
provisionally included studies conducted in school settings, but subsequently decided to report
school-based studies separately [15].
Intervention. Eligible studies included any intervention that aimed to increase the avail-
ability and accessibility of condoms (male or female) through provision of free (or financially
subsidized) condoms. Studies providing coupons for redemption of condoms were eligible for
inclusion. We only included studies where condom distribution was an integral component of
the intervention: condoms had to be provided with the clear goal of increasing accessibility
and/or affordability and not used only as an incentive for participation or provided as samples.
Condoms must have been available throughout the intervention period. We excluded inter-
ventions described as “brief” and studies in which condoms were distributed along with other
forms of contraceptives and with a strong focus on preventing pregnancy rather than prevent-
ing STIs.
CDI could be integrated with or supplemented by any co-interventions that directly or
indirectly enhance the effect of condom distribution by addressing knowledge, attitudes,
behaviors, and the social and economic contexts influencing condom use including: a)
social marketing/mass-media campaigns to promote condom use; b) risk-reduction or
other prevention interventions directly or indirectly promoting condom usage acceptance;
c) community-wide mobilization efforts to support condom use; d) changes in policies or
laws to promote condom use; or e) individual-, couple-, or group-level behavioral inter-
ventions (e.g., counseling, motivational interviewing). Evaluations of programs with co-
interventions outside of these five categories (e.g., HIV testing and/or needle exchange
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programs) were not eligible, unless condom distribution outcome data were stratified and
reported separately from those of the co-interventions. We also excluded theory-based
behavioral interventions (e.g., cognitive-behavioral group interventions [16]) that aim to
reduce sexual risk behavior and/or promote condom use, without making condoms widely
available and accessible to participants.
Comparator. Comparators could have included no intervention (e.g., a pre-intervention
condition), or a component of the intervention apart from provision of condoms (e.g., HIV
prevention education only).
Outcomes. Our primary outcomes of interest were 1) change in HIV incidence or preva-
lence attributable to the intervention, and 2) laboratory-confirmed HIV diagnosis. As proxy
(indirect) measures for these outcomes, studies reporting sexually transmitted infection (STI)
incidence or prevalence, any variation of self-reported condom use (e.g., “at last sex,” “always
vs. sometimes,” “always vs. never,” “mean percentage of episodes using condoms,” etc.), and
self-reported number of sex partners were eligible. As condom-use outcomes are reported in
many different ways, with no single generic metric [17], we developed two standardized met-
rics as described under “Data analysis plan.” Number of sex partners was included in order to
capture the potential risk compensation effect of CDI (i.e., lower perceived risk through con-
dom use could result in an increase in number of sexual partners or other types of risky behav-
ior) [18]. We excluded studies that reported only female condom use outcomes without
providing a measure for overall condomless sex.
We had no restrictions on study eligibility based on language or publication status. We also
included all types of observational and experimental designs as long as reported data would
allow a comparison between intervention and control conditions.
Search methods
We attempted to minimize the potential for publication bias by comprehensively searching
multiple sources of studies including bibliographic databases, archives of relevant conference
abstracts, bibliographies of previous systematic reviews, bibliographies of our included studies,
and registries of clinical trials. We also contacted authors of included studies to be sure we had
not missed any of their ongoing or unpublished research.
Using a range of relevant keywords and Medical Subject Heading (MeSH) terms, we devel-
oped a comprehensive search strategy (S3 File). The search range was from January 1, 1986
(the year in which CDC first recommended consistent condom use for HIV prevention [19])
to the search date (June 23, 2015; searches updated April 17, 2017). We searched several biblio-
graphic databases including the Cochrane Central Register of Controlled Trials (CENTRAL),
PubMed, PsycINFO, and Scopus (including EMBASE records from 1996 to the present). We
improved the sensitivity of our search strategies by iteratively updating them with keywords
from relevant studies not detected in initial searches.
To augment these database searches, we also searched “grey literature” to obtain data
reported outside peer-reviewed journals. Grey literature sources included the New York Acad-
emy of Medicine’s Grey Literature Report; abstract archives of International AIDS Conference,
the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS), and the Conference on Retroviruses and Opportunistic Infections (CROI); and doctoral
dissertations through ProQuest Dissertations. We also used advanced search syntax in Google
and Google Scholar to conduct targeted searches of web sites of relevant non-government
organizations and of US federal, state, and local government HIV prevention programs. We
searched ClinicalTrials.gov at the US National Institutes of Health to identify any ongoing
RCTs.
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Methods for selection of studies
We examined studies for relevance based on geographic settings, intervention, design, types of
participants, and outcome measures, and in a step-wise fashion determined which studies met
inclusion criteria. First, using the Endnote X7.4 software [20], we excluded duplicate records
from various sources. Two study authors (AP and JB) then read the titles, abstracts, and
descriptor terms of the remaining citations to identify potentially eligible studies. After recon-
ciling their respective selections, the two reviewers independently examined the full text of
each article and determined which met our review’s inclusion criteria. Any differences arising
were resolved by discussion with a third reviewer (MM).
Data extraction and management
From studies meeting inclusion criteria, two reviewers working independently extracted data
into a pre-piloted data extraction form. They then cross-checked each other’s extracted data,
corrected errors, reconciled any disagreements as they arose, and contacted study authors to
obtain key data missing from reports.
To inform our analyses, study data was extracted by domain: a) complete citation; b) geo-
graphical setting; c) details of interventions and comparators (e.g., intervention content, dura-
tion of exposure to the intervention); d) details of participants (e.g., age, sex); e) outcomes
(e.g., definitions and descriptions of outcomes; details of how outcomes were assessed); f)
detail of study implementation (e.g., study inclusion and exclusion criteria, length of follow-
up); and g) risk of bias assessment data (i.e., details necessary to perform a bias risk assessment
using the Cochrane tool, described below).
Risk of bias assessment
We adapted and used the Cochrane Collaboration instrument for assessing risk of bias [13]
that examines individual studies across seven domains for RCTs: sequence generation, alloca-
tion concealment, blinding of participants and personnel, blinding of outcome assessment,
incomplete outcome data, selective outcome reporting, and other potential biases. For non-
RCTs, we additionally assessed risk of bias by using criteria recommended by the GRADE
Working Group (S1 File) [21].
Statistical analysis and data synthesis
Effect size calculation. For each outcome extracted from primary studies, we calculated
risk ratios (RR) and their associated 95% confidence intervals (CI). When studies reported
odds ratios (OR) for non-rare outcomes and there were insufficient data to calculate the RR,
we used the Zhang and Yu [22] method to obtain an estimate of the RR. When studies did not
report 95% CI, we calculated 95% CI from p-values or from sample sizes as necessary. When
data were insufficient to estimate CIs and assumptions could not be made about sample sizes,
we excluded the outcome from meta-analyses.
Data analysis plan. In preparation for conducting meta-analyses, we grouped data points
according to the characteristics of three domains: 1) intervention type, 2) outcome type, and 3)
population (see Table 1 for details). This paper focuses on CDI types that made condoms more
widely available per CDC’s recommendations [23]. We distinguished three types of CDI based
on the presence of co-interventions and use of coupons to provide access to condoms: Ongo-
ing, Ongoing-Plus, and Coupon-based. We separately analyzed data on a group of CDI (Lim-
ited) that were implemented at the individual context level and were limited in terms of
frequency and/or duration of access to condoms.
Systematic review and meta-analysis of community-based condom distribution interventions in the US
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We observed a wide variation in measuring and reporting of sexual risk behavior outcomes
in the literature. Given there is no universally-accepted standard metric for measuring condom
use [17], we created two standardized outcomes: a) condomless sex likelihood, at last episode
(most commonly reported, k = 5) or over a recall period (k = 3), and b) not always using con-
doms. For studies reporting condomless sex at episodes of sex other than last, we considered
those outcomes similar enough and included as condomless sex likelihood. Additionally, sex-
ual partnership outcomes were reported in two ways: mean counts of partners in the recall
period and proportion reporting more than a certain number of partners in the recall period.
In order to combine these two types, we created a “multiple sexual partnership” outcome,
assumed a Poisson distribution of the number of partners, and converted mean numbers of
partners to the proportion of participants with two or more partners.
Meta-analysis. For statistical analysis, we used the Review Manager 5 software [24].
When we identified two or more data points for the same combination of intervention-out-
come pair, we used a random-effects meta-analytic model to calculate pooled RR and 95% CI,
weighting by inverse of variance. To calculate an overall estimate within a study based on sub-
group data (e.g., condom use by males and females), we used fixed-effect models [25]. We also
assessed statistical heterogeneity for pooled data using the I2 statistic, which estimates the pro-
portion of variation in effect sizes that is explained by non-random differences in intervention
effect [26]. We explored subgroup analyses for each outcome if they were available.
Table 1. Meta-analysis plan by type of community-based condom distribution intervention, outcome, population.
Type of condom distribution intervention* Outcome Population
Ongoing (without co-intervention): Participants
had free access to unlimited number of condoms at
specific locations; and were able to get more at
essentially any time. Without co-intervention means
condom distribution (CD) itself was the only
intervention component being tested in the study
(i.e., the comparison group received the same co-
interventions, apart from the CD component; or the
comparison group received no intervention).
Ongoing-plus (with co-intervention): Similar to
above but CD was a significant component of a
multicomponent intervention (e.g., a community level
intervention including media, outreach, and CD).
Coupon-based (with co-intervention):
Participants received coupons or cards and could
exchange these for condoms at specific locations.
CD was a significant component of a
multicomponent intervention
1. Condomless sex likelihood: Self-report of
having unprotected sex at last episode, or the
proportion of a set of episodes that were
unprotected.
2. Not always using condoms: Self-report of
having at least one episode of condomless sex in
the recall period.
3. Multiple sexual partnership: Self-report of
having at least two (cut off as defined in studies
and can be larger) sexual partners in the recall
period.
4. HIV: Incident case of HIV infection based on
any data source such as lab reports, medical
record, surveillance reports, and self-report.
5. Other STI: Incident case of non-HIV STIs
based on any data source (same as above).
Sub-analysis by short (< 1 year of follow-up)
vs. long term follow-up: Short term includes
studies in which we know the length of time since
the baseline measure (or have clear information
about how long the intervention was going on at
the time of the assessment), and does not
include, for example, cross-sectional studies
measuring an effect based on current presence/
absence of an intervention where we cannot
measure how long the intervention had been
going on.
Overall analysis: Combining across multiple
populations (and follow-up time points if
applicable) within a specific intervention and
outcome type.
Sub-analysis by:
a. Sex (Males/Females)
b. HIV high risk group (Drug users, MSM)
* We separately analyzed and reported a group of studies (Limited) that initially met our broad inclusion criteria, but that were implemented at the individual
context level and were limited in terms of frequency and/or duration of access to condoms (e.g., participants could take as many condoms as they wanted,
but only at motivational sessions or when they made contact with a street outreach worker). See S5 File for details.
https://doi.org/10.1371/journal.pone.0180718.t001
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Assessment of evidence quality
We used the GRADE approach [27] to assess the quality of evidence for each outcome across
the literature. The GRADE methodology defines “quality of evidence” as “the extent of our
confidence that the estimates of effect are correct" [13]. The quality rating across studies has
four levels: high, moderate, low, or very low. Data from randomized trials are considered to be
of high quality but can be downgraded for any of five reasons: risk of bias, indirectness of evi-
dence, unexplained heterogeneity or inconsistency of results, imprecision of results, high prob-
ability of publication bias. In contrast, data from non-RCTs are considered to be of low-
quality, but can be upgraded for any of three reasons: large magnitude of effect, plausible con-
founding that would increase confidence in an estimated effect, the presence of a dose-
response gradient. We used GRADEpro software [28] to generate GRADE evidence profiles.
Results
Our searches identified 10,947 records: 10,921 from database searches and 27 from other
sources (Fig 1). After removing 4,406 duplicates, two authors reviewed titles, abstracts, and
keywords for the remaining 6,542 records and excluded an additional 6,273 citations for failing
to meet inclusion criteria. They then examined the full text of 269 articles for further assess-
ment, of which 247 were excluded for not meeting at least one of our inclusion criteria (see S4
File for citations): intervention content not including condom distribution (k = 148); condom
distribution not an integral part of the intervention (k = 38); multifaceted intervention without
stratified outcome data for the effect of CDI (k = 8); not reporting outcomes of interest
(k = 12); not reporting sufficient quantitative information to calculate a point estimate and/or
CI (k = 2); and other reasons such as being conducted outside of the US or not being a primary
program evaluation (k = 39).
We corresponded with 20 study authors and other experts seeking information on ongoing
or unpublished research and received responses from 10, but this process did not yield any
new studies. In the end, we analyzed data for 22 studies that met our general definition of CDI,
of which 16 studies were conducted in community settings and six in school settings (sepa-
rately reported; [15]). Of 16 community-based studies, seven were considered “Limited” in
terms of provision of condoms and are only presented in the appendix (see S5 File), while the
rest of this manuscript focuses on the remaining nine community-based CDI studies.
Characteristics of included studies
Table 2 presents characteristics of the nine included studies. All were published in peer-
reviewed journals between 1992 and 2013 and carried out within a 22-year time span (1989 to
2011) in 10 US states: California (k = 2), Connecticut, Louisiana, Massachusetts, Minnesota,
Nevada, Oregon, Pennsylvania, Texas, and Washington (k = 2). All studies but one were non-
RCT in design. Eight reported only behavioral outcomes (e.g., condom-use related), and one
reported only incident non-HIV STIs. Follow up ranged from five to 36 months.
Studies were diverse in respect to target populations as follows: general population, residing
in or approached in a high HIV prevalence area (k = 2, 22% of total) [30, 32]; youth or young
adults (k = 6, 67%) [31, 33–37]; drug users (k = 1, 11% of total) [29].
One of the nine studies [32] reported two distinct intervention-control comparisons, result-
ing in a total of 10 unique comparisons for our data analysis. Of the 10 unique comparisons,
four (40%) assessed the effect of Ongoing CDI, without co-interventions [29–32]; four (40%)
assessed Ongoing CDI, with co-interventions [32–35], and two (20%) assessed condom cou-
pon or card distribution, with co-interventions [36, 37].
Systematic review and meta-analysis of community-based condom distribution interventions in the US
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Risk of bias in included studies
Of the nine included studies, only one [37] was an RCT. It was unclear from the report
whether the trial’s methods for randomization and to control for attrition bias were adequate.
The measures undertaken for blinding of participants, personnel, and outcome assessors were
adequate.
The remaining studies, all non-RCTs, were subject to additional high risk of bias. This was
partly due to the fact that the vast majority of outcomes (condom use and of number of sexual
partners) were self-reported by respondents (i.e., potentially biased due to social desirability
norms, especially in a study’s intervention arm). Thus, we determined that measurement of
outcome was significantly flawed in all reported behavioral outcomes. Further, several studies
used single-arm pre-post design to assess the effect of condom use [29, 30, 32, 33] and there-
fore were at high risk of bias due to secular trends (i.e., in the absence of a distinct control con-
dition, the observed effect can be partially or entirely due to other existing interventions or
Fig 1. Searching and screening of scientific records for systematic review of community-based
condom distribution interventions in the United States (search January 1, 1986 to April 17, 2017).
*Databases searched: SCOPUS, PubMed, PsycINFO, Cochrane Central Register of Controlled Trials. †We
separately analyzed and reported this group of studies. They initially met our broad inclusion criteria, but were
implemented at the individual context level and were limited in terms of frequency and/or duration of access to
condoms (e.g., participants could take as many condoms as they wanted, but only at motivational sessions or
when they made contact with a street outreach worker). See S5 File for details. ‡Given the differences
between youth populations in school and high-risk adult populations in community settings, we decided while
screening of studies was in progress to disseminate findings of school-based studies separately.
https://doi.org/10.1371/journal.pone.0180718.g001
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Table 2. Characteristics of community-based condom distribution programs in the United States included in systematic review, by intervention
categorya.
Author & Year Study location
(Setting)
Data
Collection
Year
Target population
(inclusion/exclusion
criteria)
Demographic
information
Co-interventions
(Provider / delivery
modality)b
Study designc
(Number of
participants)
Reported
outcomes
Follow-
up
period
Ongoing (without co-interventions)
Calsyn 1992
[29]
Seattle, WA
(Urban)
Dec 1989—
May 1990
Male drug users (all
men receiving
outpatient drug abuse
treatment at the VA
Med. Center)
Age: 8.7% <35 yrs.;
66.1% 35–44; 17.4%
45–55; 7.8% >55
Sex (% F): 0%
Race/Ethnicity: 76.7%
White; 22.3% Black;
1.0% Other
None (N/A) Experimentald Pre-
Post Single-Arm
Cluster (103)
Mean use of
condoms for
vaginal
intercourse
events (past 2
mo.)
5 mo.
Cohen 1999
(Area B) [30]
New Orleans, LA
(Urban)
1994–1996 African-American men
(age 15–45 yrs.,
approached in high risk
neighborhoods of New
Orleans)
Age: mean 29.3 yrs.
Sex (% F): 0%
Race/Ethnicity: 100%
Afr. Amer.
None (N/A) Single-Arm Pre-
Post Cross-
Sectional (940)e
Condom use at
last sex; At least
2 sex partners
(past yr.)
1 yr; 2
yrs.
Eisenberg
2013 [31]
Statewide, MN
(Urban/rural)
2010–2011 Young adults
(undergraduate student
recruited from selected
colleges/ universities,
age 18–24 yrs., sex.
active in the past yr,
and not married)
Age: range 18–24 yrs.
Sex (% F): 63%
Race/Ethnicity: 83.6%
White; 3.0% Black;
2.8% Hisp.; 5.5%
Asian/Pacific Islander;
2.3% Amer. Indian/
Alaskan Native; 2.9%
mixed/other
None (N/A) Ecologic (6,318) No condom at
last intercourse
N/A
Ross 2004
(Comparison
arm) [32]
Houston/ Harris
County, TX
(Urban)
1998–2000 Gen. population (age
18+ yrs. and living in zip
codes with relatively
high rates of syphilis)
Age: NR
Sex (% F): 41.6%
Race/Ethnicity: 92.3%
Afr. Amer.; 2.2%
White
None (N/A) Experimental
Single-Arm Pre-
Post Cross-
Sectional (789
across 2 cross-
sect. waves)
Proportion of
times used
condoms of times
had sex (past 4
weeks); Number
of sex partners
(past 4 weeks)
2 yrs.
Ongoing-plus (with co-interventions)
Alstead 1999
[33]
King County,
Seattle area, WA
(Urban)
1995 Youth (age 15–17 yrs.) Age: mean(SD) 16.0
(.8) yrs.
Sex (% F): 48%
Race/Ethnicity: 38%
White; 30% Afr.
Amer.; 16% Asian/
Pacific Islander; 16%
other (incl. Hisp.,
Native Amer., and
multi-ethnic)
Behavioral & skill
building (Media)
Pre-Post Single-
Arm Cross-
Sectional (1,425
across 3 cross-
sectional waves)
Condom use at
last intercourse
1–7 mo.
Lauby 2000
[34]
Pittsburgh, PA;
West
Philadelphia, PA;
Portland, OR
(Urban)
1993–1996 High risk women (age
15–34 yrs., approached
in a high risk
community, sexually
active in the past 30
days)
Age: mean 25 yrs.Sex
(% F): 100%Race/
Ethnicity: 73.1% Afr.
Amer.
Behavioral & skill
building + Street
outreach (Peers
+ Media)
Experimental
Double-Arm Pre-
Post Cross-
Sectional (3,723)
Condom use
during most
recent sex;
Consistent
condom use
(past 30 days)
36 mo.
Ross 2004
(Intv. arm) [32]
Houston/ Harris
County, TX
(Urban)
1998–2000 General population
(age 18+ yrs., living in
zip codes with relatively
high rates of syphilis)
Age: NR
Sex (% F): 37.6%
Race/Ethnicity: 91.0%
Afr. Amer.; 4.2%
White
Behavioral and skill
building + Street
outreach (Peers
+ Media)
Experimental
Single-Arm Pre-
Post Cross-
Sectional (841
across 2 cross-
sect. waves)
Proportion of
times used
condoms of times
had sex (past 4
weeks); Number
of sex partners
(past 4 weeks)
2 yrs.
Sellers 1994
[35]
Boston, MA;
Hartford, CT
(Urban)
Sept
1989-Dec
1991
Latino youth (age 14–
20 yrs.)
Age: range 14–20 yrs.
Sex (% F): NR
Race/Ethnicity: 100%
Hisp. (94% Puerto
Rican)
Gen. HIV & sex
health edu
+ Formal CUT
+ Street outreach
(Professional staff
+ Peers + Media)
Experimental Non-
RCT Double-Arm
Cluster (586)
Multiple (2+)
sexual partners
(past 6 mo.)
18 mo.
Coupon-based (with co-interventions)
(Continued)
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unknown sources). Finally, there was a risk of intervention contamination in studies where an
intervention was provided to a selected neighborhood and a similar neighborhood in the same
geographic area was used as comparison [34].
Results of data synthesis
Table 3 summarizes the evidence for the effectiveness of community-based CDI on risk of
HIV transmission by intervention type, outcome, and population. Comprehensive and
detailed results of our meta-analyses, as well as risk of bias assessments and GRADE evidence
profiles are presented in S6 and S7 Files, respectively.
Our analysis estimated that Ongoing CDI (k: number of comparisons = 4, n: number of
participants = 8,091) with pooled RR of 0.88 (95% CI 0.78 to 0.99) significantly reduced the
risk of condomless sex likelihood. For multiple sexual partnership (k = 2, n = 1,696) the RR
was 0.59 (95% CI 0.19 to 1.86). We observed significant statistical heterogeneity for each out-
come (I2 = 74.5%, p = 0.008; and I2 = 99. 1%, p<0.001; respectively). All study outcomes were
Table 2. (Continued)
Author &
Year
Study location
(Setting)
Data
Collection
Year
Target population
(inclusion/
exclusion criteria)
Demographic
information
Co-
interventions
(Provider /
delivery
modality)b
Study designc
(Number of
participants)
Reported
outcomes
Follow-
up
period
Bull 2008
[36]
CA: Oakland,
San Francisco,
Los Angeles,
San Diego;
NV: Las Vegas
(Urban)
2004–
2005
Young adult women
(15–25 yrs.)
Age: 41.9% 15–17
yrs.; 18.5% 18–19;
39.5% 20–25; 0.1%
missing
Sex (% F): 100%
Race/Ethnicity:
32.3% Afr. Amer.;
35.4% Latina;
30.1% other; 2.2%
missing
Gen. HIV & sex
health edu
+ Behavioral &
skill building
(Media)
Cross-Sectional
(3,003
interviewed at
follow-up)
Used a
condom at last
sex
7–10
mo.
Cohen 1992
[37]
Los Angeles,
CA (Urban)
NR Gen. pop.
(approached at a
public health STD
clinic)
Age: median 27.9
yrs. (men in study);
26.6 (women in
study)
Sex (% F): 40.2%
Race/Ethnicity:
20.6% Hisp.; 71.5%
Black; 4.5% White;
3% Asian; 3.5%
Other or unknown
Formal CUT
+ Behavioral &
skill building
(Professional
staff)
Randomized
Controlled Trial
(analyzed
condom distr.
and control
groups only;
503)
STD
reinfection
6–9
mo.
Legend: CD, Condom distribution; CUT, Condom use training; MSM, Men who have sex with men; N/A, Not applicable; NR, Not reported; PWID, People
who inject drugs; STD, Sexually transmitted disease.
a We separately analyzed and reported a group of studies (Limited) that initially met our broad inclusion criteria, but that were implemented at the individual
context level and were limited in terms of frequency and/or duration of access to condoms (e.g., participants could take as many condoms as they wanted,
but only at motivational sessions or when they made contact with a street outreach worker). See S5 File for details.
b Intervention category and co-interventions listed are those that comprise the unique elements tested in the study (i.e., common elements provided to both
the intervention and control group are not listed).
c Study design reflects the way reported data were analyzed in this review in order to extract an effect of condom distribution. It does not always match the
design of the study as originally implemented.
d Studies are considered experimental if investigators controlled the intervention allocation.
e Total number of respondents not reported. Maximum item-level N reported in the publication was 941 for Area B across 3 waves.
https://doi.org/10.1371/journal.pone.0180718.t002
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at high risk of bias (Fig 2). All studies were at high risk of bias for the flaws in measurement of
exposure and outcome (domain E), and all except one due to other risk of bias (domain C,
mainly secular trend and contamination; Fig 2).
For Ongoing-plus CDI, the pooled RR for condomless sex likelihood (k = 3, n = 4,494) and
multiple sexual partnership (k = 2, n = 1,243) were 0.98 (95% CI 0.88 to 1.09) and 0.37 (95%
CI 0.16 to 0.87), respectively. Heterogeneity in the effects for condomless sex likelihood was
moderate (I2 = 35%, p = 0.20), but was high across the two estimates of multiple sexual partner-
ship (I2 = 83%, p<0.001). One study measured not always using condoms (n = 3,229), with a
RR of 0.91 (95% CI 0.71 to 1.17). All analyses were affected by high risk of bias in the same
domains as those in Ongoing CDI (Fig 3).
The effect of Coupon-based CDI was assessed in two studies [36, 37] (Table 3). In the single
RCT [37], the RR for incident STI infection was as follows: 0.91 (95% CI 0.63 to 1.31) in the
overall samples; 0.85 (95% CI 0.56 to 1.29) among men; and 1.18 (95% CI 0.52 to 2.68) among
women. In a non-RCT [36], the odds ratio for condomless sex likelihood was 0.67 (95% CI
0.47 to 0.96; insufficient data to transform odds ratio to RR).
Table 3. Summary of evidence for the effectiveness of community-based condom distribution interventions by intervention type, outcome, and
population type in the United Statesa.
Outcome Population (N) Risk Ratio (95% CI) Quality of Evidenceb Citations
Ongoing (without co-interventions)
Condomless sex likelihood Overall (8,091) 0.88 (0.78–0.99) 			 [29–32]
Male (984) 0.83 (0.75–0.91) 			 [29, 30]
Drug users (51) 0.83 (0.69–1.00) 			 [29]
Multiple sexual partnership Overall (1,696) 0.59 (0.19–1.86) 			 [30, 32]
Male (907) 1.06 (0.98–1.15) 			 [30]
Ongoing-plus (with co-interventions)
Condomless sex likelihood Overall (>4,494) 0.98 (0.88–1.09) 			 [32–34]
Female (>3,229) 0.93 (0.81–1.07) 			 [34]
Not always using condoms Female (>3,229) 0.91 (0.71–1.17) 			 [34]
Multiple sexual partnership Overall (1,243) 0.37 (0.16–0.87) 			 [32, 35]
Male (NR) 0.90 (0.43–1.88) 			 [35]
Female (NR) 0.06 (0.01–0.36) 			 [35]
Coupon-based (with co-interventions)
Incident STI Overall (503) 0.91 (0.63–1.31) 			 [37]
Male (301) 0.85 (0.56–1.29) 			 [37]
Female (202) 1.18 (0.52–2.68) 			 [37]
Condomless sex likelihood Female (2,005) 0.67 (0.47–0.96)c 			 [36]
Legend: GRADE Working Group grades of evidence:
, HIGH: We are very confident that the true effect lies close to that of the estimate of the effect. Further research is unlikely to substantially change
the estimate
	, MODERATE: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different
		, LOW: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
			, VERY LOW: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.
a We separately analyzed and reported a group of studies (Limited) that initially met our broad inclusion criteria, but that were implemented at the individual
context level and were limited in terms of frequency and/or duration of access to condoms (e.g., participants could take as many condoms as they wanted,
but only at motivational sessions or when they made contact with a street outreach worker). See S5 File for details.
b See S7 for further details on quality of evidence ratings.
c Effect measure is odds ratio.
https://doi.org/10.1371/journal.pone.0180718.t003
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Fig 2. Pooled effect measures and risk of bias for the effect of “Ongoing” community-based condom distribution interventions (compared to no
condom distribution) for sexual risk behaviors in the United States. Legend: CI, Confidence interval; IV, Inverse variance. Size of red square on the
forest plots represents IV weights. See S6 for further details on risk ratio calculations. Risk of bias legend: (A) Incomplete outcome data (attrition bias); (B)
Selective reporting (reporting bias); (C) Other bias; (D) Failure to develop and apply appropriate eligibility criteria; (E) Flawed measurement of exposure
and/or outcome; (F) Failure to control for confounders; (G) Too-short or incomplete length of follow-up;— = high risk of bias; + = low risk of bias;? = unclear
risk of bias.
https://doi.org/10.1371/journal.pone.0180718.g002
Fig 3. Pooled effect measures and risk of bias for the effect of “Ongoing-plus” community-based condom distribution interventions (compared
to no condom distribution) for sexual risk behaviors in the United States. Legend: CI, Confidence interval; IV, Inverse variance. Size of red square on
the forest plots represents IV weights. See S6 for further details on risk ratio calculations. Risk of bias legend: (A) Incomplete outcome data (attrition bias);
(B) Selective reporting (reporting bias); (C) Other bias; (D) Failure to develop and apply appropriate eligibility criteria; (E) Flawed measurement of exposure
and/or outcome; (F) Failure to control for confounders; (G) Too-short or incomplete length of follow-up;— = high risk of bias; + = low risk of bias;? = unclear
risk of bias.
https://doi.org/10.1371/journal.pone.0180718.g003
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Discussion
Our systematic review found that community-based CDI in the US may reduce risky sexual
behaviors such as condomless sex and multiple sexual partnership. However, quality of evi-
dence was very low, reflecting high risk of bias and a lack of direct biological evidence for
reduced HIV incidence.
Only one of nine included studies assessed a biologic outcome (non-HIV STI incidence),
with non-significant results. Self-reported behavioral outcomes included condom use (k = 8)
and change in the number of sexual partners (k = 4). Results reached statistical significance in
only 6 out of 21 outcomes (see S7 File), including main analyses, subgroup analyses, and sin-
gle-study estimates. Significant findings were all related to outcomes of condom use (k = 4)
and number of sexual partners (k = 2). These included three condom use outcomes in studies
of Ongoing distribution, two multiple sexual partnership outcomes in Ongoing-plus studies,
and one condom use outcome in a study using the Coupon-based approach.
As outlined below, the overall body of evidence across all intervention types and for all
main and subgroup analyses was of very low quality.
In pooled data from four non-RCTs using the Ongoing approach, which is closely aligned
with CDC’s definition of CDI, we found very low-quality evidence of 12% reduction in con-
domless sex likelihood. The effect was slightly more pronounced in subgroup analyses of two
studies reporting male participant outcomes and two with follow-up12 months. Very low-
quality evidence from two studies showed no difference in self-reported multiple sexual part-
nership. All other outcomes examined for this approach were not statistically significant, with
evidence quality rated very low.
In the Ongoing-plus model, we found very low-quality evidence from a pooled analysis of
three non-RCTs that condomless sex likelihood did not differ between groups. However,
across two of these studies, both at high risk of bias, there was very low-quality evidence show-
ing a 63% reduced risk of multiple sexual partnership. An apparent 94% risk reduction was
shown in one study reporting data from female participants. All other outcomes examined for
this approach were not statistically significant, with evidence quality rated very low.
In the Coupon-based model, the quality of evidence was again very low. The single included
RCT provided very low-quality evidence for no statistically significant effect on incident STIs.
One non-RCT in women provided very low-quality evidence associating the intervention with
reduced condomless sex likelihood.
Overall, while some evidence suggests CDI may help to reduce HIV risk behavior by about
12–15%, with larger estimated reductions in multiple sexual partnership, it is very uncertain
that such programs have any impact at all on HIV incidence. Evidence quality for all outcomes
was very low, and was graded down for serious risk of bias and serious indirectness (i.e., the
use of behavioral outcome data as a proxy for HIV incidence is very indirect evidence for any
change in HIV incidence). Serious inconsistency (i.e., conflicting study results) was a problem
in the analyses reporting change in multiple sexual partnerships.
Limitations of the review
Our review is a comprehensive assessment of the US scientific literature on the effectiveness of
CDI. We used comprehensive search strategies in four important bibliographic databases,
searched grey literature, examined bibliographies of relevant studies and used rigorous meth-
ods throughout our review process. As with any systematic review, however, our review has
limitations. While the bibliographic databases we searched had most likely, taken together,
indexed all relevant peer-reviewed studies, it is possible that a study was indexed only in a data-
base we did not search. However, this is unlikely. Although we searched a wide range of grey
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literature sources with the hope to find documents reporting CDI program data from commu-
nity-based organizations, local public health agencies and other potential CDI implementers,
the grey literature itself is nearly inexhaustible and it is conceivable that we could have missed
some reports. Similarly, we do not think it is likely that is likely that we missed any such
studies.
More serious review limitations arise in the nature of the studies that we found. Very low-
quality evidence severely limits our ability to be certain of intervention effects. With most stud-
ies relatively old, important social changes and breakthroughs in HIV prevention and treat-
ment since they were conducted could mean that their effects would now be different. Across
all included studies, there was little consistency in terms of populations, interventions and out-
comes examined. Studies do not examine CDI in all high-risk U.S. populations. Use of com-
posite outcomes by some investigators forced us to exclude some studies.
Most (eight of nine) studies included in this review were non-RCTs and were at high risk of
several kinds of biases (S6 File). High risk of bias was an important consideration in our
GRADE analyses. With very low quality evidence, an intervention’s true effects may be sub-
stantially different from those we have calculated. This applies not only to the size but also to
the direction of effect. Critically, nearly all reported outcomes were very indirect, reflecting
only sexual risk behaviors. Thus, our confidence in how well these effect estimates translate to
actual reduction in risk of HIV transmission is very limited.
We also observed substantial statistical heterogeneity (I2 > 75%) in several of the pooled
analyses, reflecting variations in study designs, settings, and populations. These also mani-
fested in the form of wider 95% CIs around point estimates. Lastly, we identified substantial
variation in the impact of various types of CDI, partially explained as we have shown, by differ-
ences in specific content of programs as well as other sources of heterogeneity.
In the process of this review, we also identified seven non-RCT community-based CDI
studies that were considered Limited in terms of provision of condoms [38–44]. Overall, evi-
dence from these seven studies was also very low quality and not substantially different from
other CDI models in this review (see S5 File).
Our review did not identify any condom distribution programs explicitly targeting sex
workers in the US. Only one study approached young and sexually active women in a high-
risk community [33]. We offer two plausible explanations for this observation. First, despite its
widespread presence, sex work has remained an illegal activity in nearly all of the US, making
it an underground industry that is hard to study. Due to criminalization of sex work, there are
also very few geographically definable areas or communities in the U.S that lend themselves to
community-wide condom distribution programs for sex workers. Secondly, in contrast to the
HIV epidemic in southern African and other settings where sex workers are among the most
affected key populations, MSM and PWID are the two most affected populations in the US
HIV epidemic and are those to which public health authorities pay the most attention.
We did not formally assess risk of publication bias as we did not pool10 studies in any
meta-analysis. We identified and extracted data from all comparative studies reporting out-
comes in which the relative effect of CDI could be isolated or stratified from other interven-
tions. However, we excluded eight studies from analysis because such data could not be
analyzed separately. Had investigators of several studies actually stratified condom distribution
outcome data in the presence of other interventions, we could potentially have included addi-
tional studies. This problem is not uncommon. O’Reilly and colleagues [45] describe a system-
atic review of free condom distribution programs that they started but abandoned, even after
identifying 34 studies (from the global literature) that apparently met inclusion criteria.
O’Reilly reported that it was “not possible to isolate the effect of free condom distribution
from other co-occurring interventions” [45].
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As we limited our review to US-based studies, our findings are highly applicable to popula-
tions residing in the US and reached through community settings. However, most of the
included studies were rather old, with all but one [31] published before 2010; many were pub-
lished in the 1990s, before triple ART regimens came into widespread use, and before pre-
exposure prophylaxis (PrEP) became available. It is likely that today’s US populations at high
HIV risk (e.g., MSM) might respond differently to CDI, although the direction of this response
is yet to be examined. For instance, as a result of increased uptake of HIV testing in recent
years, a substantial portion (86%) of HIV infected persons are now aware of their status [3].
Those who are aware of their HIV status may be more likely to adopt safer sexual practices
such as serosorting or using condoms with partners whose HIV status is unknown [46, 47].
On the other hand, due to the availability of more effective and simpler ART regimens, people
with HIV can now live an almost normal life. Population groups at risk of HIV infection may
not perceive HIV as a fatal disease anymore and may engage in risky sexual behavior. Individ-
uals who are on treatment but are not virally suppressed may still transmit the infection to
their uninfected sexual or drug-injecting partners. This latter phenomenon may have contrib-
uted to the recent resurgence of HIV among certain HIV high-risk groups such as young Afri-
can-American MSM [48]. Finally, as we report above, condom use at last episode of sex may
not fully capture changes in condom use over time in response to an intervention, notwith-
standing that it is one of the most frequently reported outcomes [49].
Conclusions
Given the very low-quality evidence found in our review, we cannot draw firm conclusions
about the relative effectiveness of any of the three CDI models (i.e., ongoing, ongoing-plus,
and coupon-based) in reducing HIV incidence or risk of HIV infection. Community-based
CDI may reduce some risky sexual behaviors, but the evidence for any reduction is limited
and of low quality. Lack of biological outcomes precludes assessing the link between commu-
nity-based CDI and HIV incidence. Rigorous assessment of CDI effectiveness through well-
executed studies of appropriate design (e.g., community-based cluster RCTs with adequate
duration of follow-up and measurement of HIV biological outcomes) in a range of high-risk
populations would provide stronger evidence for nuanced assessments of CDI effectiveness.
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